Brain insulin resistance plays an important role in development and progress of Alzheimer’s disease; most significantly, it increases oxidative stress and stimulates Aβ42 production and Tau protein phosphorylation. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.